+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Statins and myocardial remodelling: cell and molecular pathways



Statins and myocardial remodelling: cell and molecular pathways



Expert Reviews in Molecular Medicine 13: E22



The advent of statins has revolutionised the treatment of patients with raised plasma cholesterol and increased cardiovascular risk. However, the beneficial effects of this class of drugs are far greater than would be expected from lowering of cholesterol alone, and they appear to offer cardiovascular protection at multiple levels, primarily as a result of their pleiotropic activity. Indeed, their favourable effects on the heart seem to be mediated in part through reduced prenylation and subsequent inhibition of small GTPases, particularly those of the Rho family. Such statin-mediated effects are manifested by reduced onset of heart failure and improvements in cardiac dysfunction and remodelling in heart failure patients. Experimental studies have shown that statins mediate their effects on the two major resident cell types of the heart--cardiomyocytes and cardiac fibroblasts--and thus facilitate improvement of adverse remodelling of ischaemic or non-ischaemic aetiology. This review examines evidence for the cellular effects of statins in the heart, and discusses the underlying molecular mechanisms at the level of the cardiomyocyte (hypertrophy, cell death and contractile function) and the cardiac fibroblast (differentiation, proliferation, migration and extracellular matrix synthesis). The prospects for future therapies and ongoing clinical trials are also summarised.

(PDF emailed within 0-6 h: $19.90)

Accession: 055911788

Download citation: RISBibTeXText

PMID: 21718586

DOI: 10.1017/S1462399411001931


Related references

Molecular pathways in myocardial development: a stem cell perspective. Cardiovascular Research 58(2): 264-277, 2003

Molecular pathways and agents for lowering LDL-cholesterol in addition to statins. Pharmacology and Therapeutics 126(3): 263-278, 2011

Molecular imaging of cardiac remodelling after myocardial infarction. Basic Research in Cardiology 113(2): 10, 2018

The signals and molecular pathways involved in human menstruation, a unique process of tissue destruction and remodelling. Molecular Human Reproduction 2(2): 77-92, 1996

Decreased cell-to-cell coupling due to hypertension-related myocardial remodelling facilitates occurrence of malignant arrhythmias. European Heart Journal 22(Abstract Supplement): 99, 2001

From Inflammation to Fibrosis-Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities. Current Heart Failure Reports 14(4): 235-250, 2017

Intracoronary infusion of bone marrow-derived mononuclear cells abrogates adverse left ventricular remodelling post-acute myocardial infarction: insights from the reinfusion of enriched progenitor cells and infarct remodelling in acute myocardial infarction (REPAIR-AMI) trial. European Journal of Heart Failure 11(10): 973-979, 2010

Myeloid cell-derived LRG attenuates adverse cardiac remodelling after myocardial infarction. Cardiovascular Research 109(2): 272-282, 2016

Ultrastructural remodelling in the heart with special reference to myocardial cell death in the senescence accelerated mouse. Japanese Circulation Journal 60(7): 436-437, 1996

Impact of different bone marrow cell preparations on left ventricular remodelling after experimental myocardial infarction. European Journal of Heart Failure 10(2): 119-124, 2008

RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction. Cardiovascular Research 103(2): 206-216, 2015

SIRT1 regulates MAPK pathways in vitiligo skin: insight into the molecular pathways of cell survival. Journal of Cellular and Molecular Medicine 18(3): 514-529, 2015

Molecular and cell biology of native coronary and vein-graft atherosclerosis: regulation of plaque stability and vessel-wall remodelling by growth factors and cell-extracellular matrix interactions. Coronary Artery Disease 8(3-4): 213-224, 1997

Injectable biodegradable hydrogels for embryonic stem cell transplantation: improved cardiac remodelling and function of myocardial infarction. Journal of Cellular and Molecular Medicine 16(6): 1310-1320, 2012

Cellular and molecular remodelling of a host cell for vertical transmission of bacterial symbionts. Proceedings. Biological Sciences 283(1833), 2017